Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Among patients with Parkinson disease with obstructive sleep apnea, PAP therapy improved cognitive function over 6 months.

Late-breaking findings on pulmonology, critical care, and sleep medicine will be presented at the American Thoracic Society ...

SAN FRANCISCO, May 6, 2025 /PRNewswire/ -- The global continuous positive airway pressure devices market size is anticipated to reach USD 2.62 billion by 2030, growing at a CAGR of 5.45% during ...